loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 204052 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACETAMINOPHEN (1)

filter

01 SANDOZ (1)

filter

01 SOLUTION;INTRAVENOUS (1)

filter

01 1GM/100ML (10MG/ML) (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION;INTRAVENOUS
1GM/100ML (10MG/ML)
ACETAMINOPHEN
USA
204052
2016-03-22
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 204052

Looking for CTD TGA MCC DOSSIER APPLICATION 204052 1

19

Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for A global leader in antibiotics.

One of their notable products is ACETAMINOPHEN, with a corresponding application number 204052 and regulatory information .

proudly manufactured in the

approval since 2016-03-22

Sandoz B2B's ACETAMINOPHEN SOLUTION;INTRAVENOUS, medication with 1GM/100ML (10MG/ML) of ACETAMINOPHEN.

Post Enquiry
POST ENQUIRY